Applied Genetic Technologies reported $14.49M in Operating Expenses for its first fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Applied Genetic Technologies AGTC:US $ 14.49M 627K
Avrobio Inc AVRO:US 31.38M 4.49M
Biogen BIIB:US $ 2289.3M 569.2M
Bluebird Bio BLUE:US $ 248.31M 4.31M
Celldex Therapeutics CLDX:US $ 16.92M 404K
Cti Biopharma CTIC:US $ 19.51M 2.44M
Gilead Sciences GILD:US $ 3971M 438M
Insmed INSM:US $ 151.62M 27.57M
Intercept Pharmaceuticals ICPT:US $ 95.82M 15.19M
Regeneron Pharmaceuticals REGN:US $ 1791.3M 375.3M
Rigel Pharmaceuticals RIGL:US $ 39.31M 51K
Ultragenyx Pharmaceutical RARE:US $ 169.75M 36.21M